PMID- 30296291 OWN - NLM STAT- MEDLINE DCOM- 20190405 LR - 20190405 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 13 IP - 10 DP - 2018 TI - Three-dimensional holographic visualization of high-resolution myocardial scar on HoloLens. PG - e0205188 LID - 10.1371/journal.pone.0205188 [doi] LID - e0205188 AB - Visualization of the complex 3D architecture of myocardial scar could improve guidance of radio-frequency ablation in the treatment of ventricular tachycardia (VT). In this study, we sought to develop a framework for 3D holographic visualization of myocardial scar, imaged using late gadolinium enhancement (LGE), on the augmented reality HoloLens. 3D holographic LGE model was built using the high-resolution 3D LGE image. Smooth endo/epicardial surface meshes were generated using Poisson surface reconstruction. For voxel-wise 3D scar model, every scarred voxel was rendered into a cube which carries the actual resolution of the LGE sequence. For surface scar model, scar information was projected on the endocardial surface mesh. Rendered layers were blended with different transparency and color, and visualized on HoloLens. A pilot animal study was performed where 3D holographic visualization of the scar was performed in 5 swines who underwent controlled infarction and electroanatomic mapping to identify VT substrate. 3D holographic visualization enabled assessment of the complex 3D scar architecture with touchless interaction in a sterile environment. Endoscopic view allowed visualization of scar from the ventricular chambers. Upon completion of the animal study, operator and mapping specialist independently completed the perceived usefulness questionnaire in the six-item usefulness scale. Operator and mapping specialist found it useful (usefulness rating: operator, 5.8; mapping specialist, 5.5; 1-7 scale) to have scar information during the intervention. HoloLens 3D LGE provides a true 3D perception of the complex scar architecture with immersive experience to visualize scar in an interactive and interpretable 3D approach, which may facilitate MR-guided VT ablation. FAU - Jang, Jihye AU - Jang J AD - Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States of America. AD - Department of Computer Science, Technical University of Munich, Munich, Germany. FAU - Tschabrunn, Cory M AU - Tschabrunn CM AD - Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA, United States of America. FAU - Barkagan, Michael AU - Barkagan M AD - Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States of America. FAU - Anter, Elad AU - Anter E AD - Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States of America. FAU - Menze, Bjoern AU - Menze B AD - Department of Computer Science, Technical University of Munich, Munich, Germany. FAU - Nezafat, Reza AU - Nezafat R AD - Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States of America. LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Video-Audio Media DEP - 20181008 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Contrast Media) RN - AU0V1LM3JT (Gadolinium) SB - IM MH - Animals MH - Catheter Ablation/*methods MH - Cicatrix/*diagnostic imaging/etiology/surgery MH - Contrast Media/administration & dosage MH - Disease Models, Animal MH - Endoscopy/methods MH - Epicardial Mapping MH - Feasibility Studies MH - Gadolinium/administration & dosage MH - Heart Ventricles/diagnostic imaging/pathology/surgery MH - Holography/*methods MH - Humans MH - Magnetic Resonance Imaging/methods MH - Myocardial Infarction/*complications MH - Pilot Projects MH - Swine MH - Tachycardia, Ventricular/etiology/pathology/*surgery PMC - PMC6175509 COIS- The authors have declared that no competing interests exist. EDAT- 2018/10/09 06:00 MHDA- 2019/04/06 06:00 PMCR- 2018/10/08 CRDT- 2018/10/09 06:00 PHST- 2018/04/02 00:00 [received] PHST- 2018/08/28 00:00 [accepted] PHST- 2018/10/09 06:00 [entrez] PHST- 2018/10/09 06:00 [pubmed] PHST- 2019/04/06 06:00 [medline] PHST- 2018/10/08 00:00 [pmc-release] AID - PONE-D-18-09851 [pii] AID - 10.1371/journal.pone.0205188 [doi] PST - epublish SO - PLoS One. 2018 Oct 8;13(10):e0205188. doi: 10.1371/journal.pone.0205188. eCollection 2018.